Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2017-01-12
Summary
The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Cocaine-Related Disorders
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Louis Cantilena, M.D. · Uniformed Services University of Health Science
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-06-30
- Primary Completion
- 2005-01-31
- Completion
- 2005-06-30
Countries
- United States
Study Locations
More Related Trials
-
Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1
NCT00265265 ·Status: COMPLETED ·Phase: PHASE1
-
Ritanserin in Treatment of Cocaine Dependence - 1
NCT00000187 ·Status: COMPLETED ·Phase: PHASE2
-
Interactions Between Cocaine and Ethanol and Disulfiram - 1
NCT00094289 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
NCT00051896 ·Status: UNKNOWN ·Phase: PHASE1
-
Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1
NCT00100113 ·Status: UNKNOWN ·Phase: PHASE1
-
Psychostimulant Abuse - Novel Treatment Approaches - 1
NCT00000325 ·Status: COMPLETED ·Phase: PHASE1
-
Cocaine Abuse and ADHD - 10
NCT00000275 ·Status: COMPLETED ·Phase: PHASE2
-
Interactions Between Intravenous Cocaine and Acetazolamide or Quinine
NCT01851473 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Cocaine-Methylphendidate Interaction Study - 4
NCT00015067 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
NCT02255357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
SXC-2023 Cocaine Interaction Study
NCT06343532 ·Status: COMPLETED ·Phase: PHASE1
-
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
NCT00015223 ·Status: COMPLETED ·Phase: PHASE2
-
Piracetam for Treatment of Cocaine Addiction - 3
NCT00000198 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse
NCT01846481 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
NCT01067846 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Cocaine
NCT00451230 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1
NCT00033046 ·Status: UNKNOWN ·Phase: PHASE1
-
Agonist Replacement Therapy for Cocaine Dependence
NCT00697138 ·Status: COMPLETED ·Phase: PHASE1
-
Cognitive Remediation for Cocaine Dependence
NCT01393457 ·Status: COMPLETED ·Phase: PHASE2
-
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
NCT05886582 ·Status: RECRUITING ·Phase: PHASE2
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
NCT02522325 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Potential Interactions Between Cocaine and Tolcapone - 1
NCT00033059 ·Status: UNKNOWN ·Phase: PHASE1